GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Chardan Healthcare Acquisition 2 Corp (AMEX:CHAQ.WS) » Definitions » Research & Development

Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) Research & Development : $0.00 Mil (TTM As of Jun. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Chardan Healthcare Acquisition 2 Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Chardan Healthcare Acquisition 2's Research & Development for the six months ended in Jun. 2021 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00 Mil.


Chardan Healthcare Acquisition 2 Research & Development Historical Data

The historical data trend for Chardan Healthcare Acquisition 2's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chardan Healthcare Acquisition 2 Research & Development Chart

Chardan Healthcare Acquisition 2 Annual Data
Trend Dec18 Dec19 Dec20
Research & Development
- - -

Chardan Healthcare Acquisition 2 Semi-Annual Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Research & Development Get a 7-Day Free Trial - - - - -

Chardan Healthcare Acquisition 2 Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chardan Healthcare Acquisition 2  (AMEX:CHAQ.WS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Chardan Healthcare Acquisition 2 Research & Development Related Terms

Thank you for viewing the detailed overview of Chardan Healthcare Acquisition 2's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 State Street, 21st Floor, New York, NY, USA, 10004
Chardan Healthcare Acquisition 2 Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination.

Chardan Healthcare Acquisition 2 (Chardan Healthcare Acquisition 2) Headlines